Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam
Download in electronic PDF format for $75
Abstract: The formation of microprecipitates (subvisible particles) is a critical factor when blending parenteral drug solutions prior to or during intravenous administration to a patient. In cases where compatibility is not documented, analytical screening of such mixtures for physical incompatibility would give a safer foundation for secure administration of such blends to patients. The aim of this article is to report our experiences with visual screening using a focussed (Tyndall) light beam for the detection of microprecipitates within blends of drug solutions, a method which may be used in any hospital pharmacy without use of advanced analytical instrumentation. A selection of clinically applied drug solutions was tested for precipitation upon blending in a proportion of 1:1. In order to reduce potential background particle burden, the solutions were filtered through 0.2 micrometer pore size filters prior to mixing. To detect potential precipitation, the solutions were visually inspected using two different types
Related Keywords:
Turid Veggeland, Martin Brandl, parenteral preparations, microprecipitates, precipitates, physical incompatibility, focussed light beam, Tyndall light, compatibility, visual inspection, standard operating procedure
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam
Veggeland Turid, Brandl Martin
|
Jan/Feb 2010
Pg. 78-81
|
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
|
May/Jun 2022
Pg. 219-228
|
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
|
Mar/Apr 2002
Pg. 120-122
|
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
|
Jul/Aug 2022
Pg. 309-315
|
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II
Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
|
Sep/Oct 1999
Pg. 415-420
|
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations
Jasti Bhaskara R, Saraf Poonam
|
May/Jun 2011
Pg. 259-261
|
Autoclaves for the Sterilization of Compounded Parenteral Products
Rahe Hank
|
Mar/Apr 2003
Pg. 114-116
|
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 473-478
|
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
|
May/Jun 2023
Pg. 223-229
|
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 483-486
|
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 131-139
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 396-400
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions
Martinez Juan F, Trissel Lawrence A, Gilbert Doward L Jr
|
Sep/Oct 1997
Pg. 356-358
|
Basics of Compounding: Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 441-447
|
Basics of Compounding: Compounding Solutions
Allen Loyd V Jr
|
Mar/Apr 2000
Pg. 122-125
|
Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
|
May/Jun 2020
Pg. 200-205
|
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
|
May/Jun 2020
Pg. 238-241
|
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
Jan/Feb 2021
Pg. 52-61
|
Return to Top |